TEMPLETON INSTITUTIONAL FUNDS INC
497, 1999-07-26
Previous: THQ INC, S-8, 1999-07-26
Next: BIOCHEM PHARMA INC, SC 13D/A, 1999-07-26




o ZTIFI P-1

                         SUPPLEMENT DATED JULY 21, 1999
                              TO THE PROSPECTUS OF
                       TEMPLETON INSTITUTIONAL FUNDS, INC.
                                dated May 1, 1999


On July 21,  1999,  Templeton  Institutional  Funds,  Inc.'s  Board of Directors
approved a proposal to merge the Growth Series into Templeton Growth Fund, Inc.,
subject  to  shareholder  approval.  Templeton  Growth  Fund,  Inc.'s  Board  of
Directors  also  approved  the merger.  The  investment  goal of both the Growth
Series and Templeton Growth Fund, Inc. is long-term capital growth. This goal is
fundamental,  which  means  that  it may  not  be  changed  without  shareholder
approval. The Boards believe this proposed merger will benefit shareholders.

It is anticipated that this summer  shareholders of Growth Series will receive a
proxy and proxy statement requesting their votes on the merger.

Growth  Series  will be closed to new  investors  after the close of business on
August 10, 1999. If you are a shareholder  of record as of the close of business
on August 10,  1999,  you may continue to add to your  account,  subject to your
applicable  minimum  additional  investment  amount,  or buy  additional  shares
through  reinvestment of dividend or capital gain distributions until the merger
is approved by Growth Series' shareholders.  If the merger is approved by Growth
Series'  shareholders,  the Growth  Series will also be closed to  purchases  by
existing  shareholders,  except through the  reinvestment of dividend or capital
gain distributions or through established automatic investment plans,  including
automatic salary deferrals through defined contribution plans.

Although  you may redeem your  shares,  please keep in mind that if you sell all
the shares in your account  after  August 10, 1999,  your account will be closed
and you will not be  allowed  to buy  additional  shares of Growth  Series or to
reopen your account in the Growth  Series.  If you sell your shares in the fund,
you may  reinvest  some or all of the  proceeds  in most of the  other  Franklin
Templeton Funds within 365 days without an initial sales charge.

                Please keep this supplement for future reference.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission